-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDS%20Pain%20Management%20Summary%20Quick%20Start%20Guide_final_1.pdf
July 23, 2024 - lookback)
Risk Factors and Assessments
†Most Recent MME – amount and date (most recent)
Urine Drug … Risk Factors and Assessments
†Most Recent MME: Flag if MME is greater than or equal to 50
Urine Drug
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
June 07, 2019 - Ciprofloxacin,
levofloxacin, and doxycycline are Food and Drug Administration (FDA) approved for the … antimicrobial drug portion of PEP for inhalation anthrax in adults ≥18 years of age
regardless of … Pregnant women at risk for inhalation anthrax should receive anthrax
vaccine and antimicrobial drug … CAUTION: If patient is taking blood thinners, seizure drugs, or any other drug that may
interact and … Interventions “contraindications” Specific situation in which a drug, procedure, or surgery
should
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Enhanced%20CDS%20Artifact%20Based%20on%20Pilot%20Implementation_Final.docx
October 01, 2017 - Initial Definition
Low intensity statin semantic clinical drugs (SCD) and semantic generic clinical drug … 2.16.840.1.113762.1.4.1047.107
Test Result
Low intensity semantic branded drugs (SBD) and semantic branded drug … recommend a medication at the RxNorm Ingredient level (e.g., all drugs containing atorvastatin), Clinical Drug … atorvastatin 20mg), Clinical Dose Form Group (e.g., atorvastatin/amlodipine oral forms), or Clinical Drug
-
cds.ahrq.gov/sites/default/files/workgroups/1261/CDS_Connect_WG_%20March2021_%20Summary.pdf
March 18, 2021 - The first WG member—currently developing a CDS to prevent harmful drug
interactions—is looking for the … endorsement”; that term is regulated by the Federal Trade Commission (FTC) rather than the Food
and Drug
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - • Recommendation 10: When prescribing opioids for chronic pain, clinicians should use
urine drug … testing before starting opioid therapy and consider urine drug testing at least
annually to assess for … Inclusion,
Intervention
“medication” A drug or other substance used to treat disease or injury; a … Concepts in this category include MME amount, urine drug screen results,
evidence of benzodiazepine … Intervention “Urine drug screens” Per the CDC guidelines, a urine drug screen should be conducted before
-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin%20and%20SSRIs%20Graph%20V.%205.pdf
May 18, 2020 - Warfarin and Antidepressants
Warfarin
Type of
Antidepressant
Assess risk and
take action if
necessary
Increased GI and
non-GI bleeding
risk is possible
Assess risk and
take action if
necessary
Increased GI and
non-GI bl…
-
cds.ahrq.gov/taxonomy/term/4491
July 05, 2022 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/136331/Benzodiazepine%20Patient%20Handout.pdf
January 01, 2018 - Microsoft PowerPoint - Updated Handouts - Read-Only
REDUCING MEDICATIONS SAFELY
TO MEET LIFE’S CHANGES
FOCUS ON BENZODIAZEPINE RECEPTOR AGONISTS (BZRAs)FOCUS ON BENZODIAZEPINE RECEPTOR AGONISTS & Z-DRUGS (BZRAs)
As life changes, your medication needs may change as
well. Medications that were once good for you, …
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
December 01, 2018 - equivalent (MME) calculation (most recent, verified, value [as
quantity], date in past 6 months)
• Urine drug … Alcohol and
Drug Screen
single
questions
(Intervention
logic)
OCHIN has two commonly used … screening questions related to
alcohol and drug use that are valid
indicators of risk. … :
• MME calculation (most recent, verified, value [as quantity], date in past 6 months)
• Urine drug … past year)
o Verified “single question r/t alcohol use” Observation
o Verified “single question r/t drug
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - score and individual scores and date recorded
STarT Back
STarT Back total score and date recorded
Urine Drug … Assessments:
PEG total score and individual scores and STarT Back total score and date recorded
Urine Drug … medication"
6 Patient 6
Has Pain Management Summary CDS triggered and flag Urine Drug … Screen is viewed Hover text displays: "Absence of urine drug screen and at least one … MG / Caffeine 30 MG Oral Tablet Sleep-Disordered Breathing Non-pharmacologic Treatments Urine Drug
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
September 01, 2018 - populate several
concepts, such as patient goals and opioid medication information from a prescription drug … • Urine Drug Screens: Flag if not present AND at least one opioid medication is present. … Risk Considerations (7) o
Most Recent MME O
NRme ;
MODrug … Prescription Drug Monitoring: Tests and Services. … https://www.questdiagnostics.com/home/physicians/testing-services/by-test-name/prescription-
drug-monitoring
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - J Am
Coll Cardiol. 2019;73(24):e285-e350.
8 US Federal Drug and Food Administration. … pregnancy; still advises most pregnant
patients should stop taking statins 2021; https://www.fda.gov/drugs/drug-safety-and … https://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions
https://www.fda.gov/drugs/drug-safety-and-availability … fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy
https://www.fda.gov/drugs/drug-safety-and-availability … fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy
https://www.fda.gov/drugs/drug-safety-and-availability
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - Circulation. 2014;129(25 Suppl 2):S1-45.
13 US Federal Drug and Food Administration. 2021; https:/ … /www.fda.gov/drugs/drug-safety-
and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering … https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy … https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy … https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy
-
cds.ahrq.gov/sites/default/files/workgroups/27826/CDS_Connect_WG_Slides_July_2021.pdf
January 01, 2021 - value set filter)
− Use as a “Base Element” list for “Subpopulation” expressions that
filter for drug
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
January 01, 2021 - reuse of the CDS Authoring
Tool, including:
• An AHRQ grantee continued
development of a prototype drug-drug … The Pain Management Summary Application
pain-related data, including data
from prescription drug … • Using CDS to Reduce Harm from Drug-
Drug Interactions: Case Study
of Warfarin and Non-Steroidal … extension of the Pain
Management Summary application that
integrates the Washington State Prescription
Drug … As the team continued to monitor
the role the Food and Drug
Administration will have in the
regulation
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - Federal Drug and Food Administration. 2021; https://www.fda.gov/drugs/drug-safety-
and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering … https://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions
https://www.fda.gov/drugs/drug-safety-and-availability … fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy
https://www.fda.gov/drugs/drug-safety-and-availability … fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy
https://www.fda.gov/drugs/drug-safety-and-availability
-
cds.ahrq.gov/sites/default/files/CDS_Connect_2024_Final_Report.pdf
January 01, 2024 - Food and Drug Clinical Decision Support Software guidance
• Introducing artifact metadata fields to
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2023.pdf
January 01, 2023 - artifact metadata fields to encourage CDS developer and artifact authors to reflect on both the
Food and Drug
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
January 01, 2020 - improvements, members of the CDS community repurposed the CDS Authoring
Tool to develop a prototype drug-drug … The team also regularly monitored relevant environmental factors (e.g.,
analyzing Food and Drug Administration … including:
• An AHRQ grantee repurposed the CDS Authoring Tool open source code to develop a
prototype drug-drug … Management Summary
application to provide additional pain-related data, including data from prescription drug
-
cds.ahrq.gov/taxonomy/term/93761
May 31, 2022 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates